MTZ vs RTX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MasTec (MTZ) presents a stark contrast between explosive growth and extreme valuation. While the Piotroski F-Score of 4/9 indicates stable financial health, the stock is trading at a massive premium, with a current price of $370.55 far exceeding both the Graham Number ($69.17) and the growth-based Intrinsic Value ($149.86). Despite strong analyst support and impressive YoY earnings growth of 92.8%, the combination of bearish insider selling, a weak technical trend (10/100), and razor-thin profit margins (2.79%) suggests significant downside risk if growth targets are missed.
RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.
Compare Another Pair
Related Comparisons
MTZ vs RTX: Head-to-Head Comparison
This page compares MasTec, Inc. (MTZ) and RTX Corporation (RTX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.